An Emerging Multi-mechanism and Multi-modal Approach in Interventional Glaucoma Therapy.

The glaucoma treatment paradigm is in evolution. The topical medications-first approach is limited by significant barriers such as high rates of nonadherence and side effects including ocular surface disease. The era of interventional glaucoma has seen the development of selective laser trabeculoplasty (SLT), procedural pharmaceuticals, and minimally invasive glaucoma surgeries (MIGS).

Assessment of measurement variability across automated biometry devices.

Purpose: To evaluate measurement variability between different readily available automated biometric devices for the purposes of improving surgeon decision making for phakic intraocular lens (IOL) sizing.

Setting: Private practice (Houston, TX, USA).

Design: Prospective, single center, bilateral, non-randomized, open-label, observational study.

Capsular Waves: A Warning Indicator for Potentially Malpositioned Intraocular Lenses.

Purpose: To share examination findings of the lens capsule which may act as an indicator for malpositioned intraocular lenses (IOL).

Setting: Single large multi-specialty private practice, Houston, Texas, USA.

Design: Focused, observational case series.

Standalone interventional glaucoma: evolution from the combination-cataract paradigm.

One of the most impactful recent developments in the glaucoma community has been the concept of interventional glaucoma. In brief, this paradigm shift involves proactive rather than reactive intervention to address glaucoma earlier in the disease process, including in both standalone and combination-cataract settings. By intervening earlier with minimally invasive surgical, laser, or drug-delivery treatments instead of prolonged topical medications, interventional glaucoma aims to take the burden of medication compliance off the patient.